Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás

Detalhes bibliográficos
Autor(a) principal: Zago Silveira Ázara, Cinara
Data de Publicação: 2014
Outros Autores: Silva Araújo, Eduardo, Magalhães, Juliana Cristina, Goreti Amaral, Rita
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/443
Resumo: Introduction: Although there are quality control standards for cytopathology testing, most Brazilian laboratories show indicators below the expected. Objective: To evaluate five indicators for internal monitoring of the quality of Unified Health System-accredited private laboratories, monitored and non-monitored by an External Quality Monitoring Laboratory in the State of Goiás. Method: Cross-sectional study. A total of 153,258 tests performed in 44 laboratories were included, among which 14 were monitored e 30 non-monitored, from January 2012 to December 2012, using data from Siscolo. Results: The monitored laboratories showed 1,837 altered tests, with 855 atypical squamous cells, 905 intraepithelial lesions and 350 high grade intraepithelial lesions, while the non- monitored laboratories showed 2,535 altered tests, with 1,436 atypical squamous cells, 890 intraepithelial lesions, and 244 high grade intraepithelial lesions. Approximately 60% of the monitored laboratories and 26% of the non- monitored ones showed a positivity rate of ≥ 3%, while 72% of the monitored laboratories and 10% of the non- monitored ones showed a percentage of ≥ 0.4% of the tests compatible with high grade intraepithelial lesion among satisfactory tests. Approximately 7% of the monitored laboratories and 29% of the non-monitored ones showed a percentage of ≥ 60% of atypical squamous with undetermined significance among the altered studies. Conclusion: Most laboratories that presented indicators within the recommended parameters were participating in the monitoring process of external quality.
id INCA-1_b503d05ea18517c7165d50b89b1c83a1
oai_identifier_str oai:rbc.inca.gov.br:article/443
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of GoiásEvaluación de Índices de Calidad de Exámenes Citopatológico del Cuello Uterino en Laboratorios Privados del Estado de Goiás Acreditados por el Sistema Único de SaúdeAvaliação dos Indicadores da Qualidade dos Exames Citopatológicos do Colo do Útero de Laboratórios Privados do Estado de Goiás Credenciados pelo Sistema Único de SaúdeNeoplasias do Colo do Útero/diagnósticoEsfregaço VaginalControle de QualidadeEducação ContinuadaBrasilUterine Cervical Neoplasms/diagnosisVaginal SmearsQuality ControlEducation, ContinuingBrazilNeoplasias del Cuello Uterino/diagnósticoFrotis VaginalControl de CalidadEducación ContinuaBrasilIntroduction: Although there are quality control standards for cytopathology testing, most Brazilian laboratories show indicators below the expected. Objective: To evaluate five indicators for internal monitoring of the quality of Unified Health System-accredited private laboratories, monitored and non-monitored by an External Quality Monitoring Laboratory in the State of Goiás. Method: Cross-sectional study. A total of 153,258 tests performed in 44 laboratories were included, among which 14 were monitored e 30 non-monitored, from January 2012 to December 2012, using data from Siscolo. Results: The monitored laboratories showed 1,837 altered tests, with 855 atypical squamous cells, 905 intraepithelial lesions and 350 high grade intraepithelial lesions, while the non- monitored laboratories showed 2,535 altered tests, with 1,436 atypical squamous cells, 890 intraepithelial lesions, and 244 high grade intraepithelial lesions. Approximately 60% of the monitored laboratories and 26% of the non- monitored ones showed a positivity rate of ≥ 3%, while 72% of the monitored laboratories and 10% of the non- monitored ones showed a percentage of ≥ 0.4% of the tests compatible with high grade intraepithelial lesion among satisfactory tests. Approximately 7% of the monitored laboratories and 29% of the non-monitored ones showed a percentage of ≥ 60% of atypical squamous with undetermined significance among the altered studies. Conclusion: Most laboratories that presented indicators within the recommended parameters were participating in the monitoring process of external quality.Introducción: Aunque existen normas para el control de calidad del examen citopatológico, la mayoría de los laboratorios brasileños presentan indicadores inferiores a lo esperado. Objetivo: Evaluar cinco indicadores de Supervisión interno de calidad de los laboratorios privados acreditados por el Sistema Único de Salud, supervisados y no supervisados por un Laboratorio de Supervisión Externo de Calidad en el Estado de Goiás. Método: Estudio transversal. En dicho estudio se incluyeron 153.258 exámenes los cuales fueron realizados en 44 laboratorios (14 supervisados y 30 no supervisados) de enero a diciembre del 2012, con base en los datos del Siscolo. Resultados: Los laboratorios supervisados mostraron 1.837 exámenes anormales, de los cuales 855 determinaron células escamosas defectuosas o atípicas, 905 lesiones intraepiteliales y 350 lesiones intraepiteliales de alto grado; por otra parte, los no supervisados identificaron 2.535 exámenes anormales, con 1.436 células escamosas defectuosas o atípicas, 890 lesiones intraepiteliales y 244 lesiones intraepiteliales de alto grado. Aproximadamente el 60% de los laboratorios supervisados y el 26% de los no supervisados mostraron positividad ≥ 3%, el 72% de los supervisados y el 10% de los no supervisados presentaron un porcentaje de exámenes compatibles con lesión intraepitelial de alto grado entre los exámenes satisfactorios ≥ 0,4%. Aproximadamente el 7% de los supervisados y el 29% de los no supervisados presentaron un porcentaje de células escamosas defectuosas o atípicas con significado indeterminado entre los exámenes anormales ≥ 60 %. Conclusión: La mayoría de los laboratorios que presentan indicadores dentro de los parámetros recomendados si participan del control/Supervisión externo de calidad.Introdução: Embora existam normas de controle da qualidade dos exames citopatológicos, a maioria dos laboratórios brasileiros apresenta indicadores abaixo do esperado. Objetivo: Avaliar cinco indicadores de monitoramento interno da qualidade dos laboratórios privados, credenciados pelo Sistema Único de Saúde, monitorados e não monitorados por um Laboratório de Monitoramento Externo da Qualidade no Estado de Goias. Método: Estudo transversal. Foram incluídos 153.258 exames realizados em 44 laboratórios, sendo 14 monitorados e 30 não monitorados, de janeiro a dezembro de 2012, utilizando dados do Siscolo. Resultados: Os laboratórios monitorados apresentaram 1.837 exames alterados; dos quais 855 foram classificados como atipias em células escamosas, 905 lesões intraepiteliais e 350 lesões intraepiteliais de alto grau; enquanto os não monitorados apresentaram 2.535 exames alterados, com 1.436 atipias em células escamosas, 890 lesões intraepiteliais e 244 lesões intraepiteliais de alto grau. Aproximadamente 60% dos laboratórios monitorados e 26% dos nao monitorados apresentaram índice de positividade ≥ 3%, 72% dos monitorados, e 10% dos não monitorados apresentaram percentual de exames compatíveis com lesão intraepitelial de alto grau entre os exames satisfatórios ≥ 0,4%. Cerca de 7% dos monitorados e 29% dos não monitorados apresentaram percentual de atipias escamosas de significado indeterminado entre os exames alterados ≥ 60%. Conclusão: A maioria dos laboratórios que apresentaram indicadores dentro dos parâmetros recomendados participa do monitoramento externo da qualidade.INCA2014-12-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/44310.32635/2176-9745.RBC.2014v60n4.443Revista Brasileira de Cancerologia; Vol. 60 No. 4 (2014): Oct./Nov./Dec.; 295-303Revista Brasileira de Cancerologia; Vol. 60 Núm. 4 (2014): oct./nov./dic.; 295-303Revista Brasileira de Cancerologia; v. 60 n. 4 (2014): out./nov./dez.; 295-3032176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/443/262Zago Silveira Ázara, CinaraSilva Araújo, EduardoMagalhães, Juliana CristinaGoreti Amaral, Ritainfo:eu-repo/semantics/openAccess2021-11-29T20:09:38Zoai:rbc.inca.gov.br:article/443Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:09:38Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
Evaluación de Índices de Calidad de Exámenes Citopatológico del Cuello Uterino en Laboratorios Privados del Estado de Goiás Acreditados por el Sistema Único de Saúde
Avaliação dos Indicadores da Qualidade dos Exames Citopatológicos do Colo do Útero de Laboratórios Privados do Estado de Goiás Credenciados pelo Sistema Único de Saúde
title Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
spellingShingle Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
Zago Silveira Ázara, Cinara
Neoplasias do Colo do Útero/diagnóstico
Esfregaço Vaginal
Controle de Qualidade
Educação Continuada
Brasil
Uterine Cervical Neoplasms/diagnosis
Vaginal Smears
Quality Control
Education, Continuing
Brazil
Neoplasias del Cuello Uterino/diagnóstico
Frotis Vaginal
Control de Calidad
Educación Continua
Brasil
title_short Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
title_full Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
title_fullStr Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
title_full_unstemmed Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
title_sort Assessment of Quality Indicators in Cervical Cytopathology Tests from Unified Health System-Accredited Private Laboratories in the State of Goiás
author Zago Silveira Ázara, Cinara
author_facet Zago Silveira Ázara, Cinara
Silva Araújo, Eduardo
Magalhães, Juliana Cristina
Goreti Amaral, Rita
author_role author
author2 Silva Araújo, Eduardo
Magalhães, Juliana Cristina
Goreti Amaral, Rita
author2_role author
author
author
dc.contributor.author.fl_str_mv Zago Silveira Ázara, Cinara
Silva Araújo, Eduardo
Magalhães, Juliana Cristina
Goreti Amaral, Rita
dc.subject.por.fl_str_mv Neoplasias do Colo do Útero/diagnóstico
Esfregaço Vaginal
Controle de Qualidade
Educação Continuada
Brasil
Uterine Cervical Neoplasms/diagnosis
Vaginal Smears
Quality Control
Education, Continuing
Brazil
Neoplasias del Cuello Uterino/diagnóstico
Frotis Vaginal
Control de Calidad
Educación Continua
Brasil
topic Neoplasias do Colo do Útero/diagnóstico
Esfregaço Vaginal
Controle de Qualidade
Educação Continuada
Brasil
Uterine Cervical Neoplasms/diagnosis
Vaginal Smears
Quality Control
Education, Continuing
Brazil
Neoplasias del Cuello Uterino/diagnóstico
Frotis Vaginal
Control de Calidad
Educación Continua
Brasil
description Introduction: Although there are quality control standards for cytopathology testing, most Brazilian laboratories show indicators below the expected. Objective: To evaluate five indicators for internal monitoring of the quality of Unified Health System-accredited private laboratories, monitored and non-monitored by an External Quality Monitoring Laboratory in the State of Goiás. Method: Cross-sectional study. A total of 153,258 tests performed in 44 laboratories were included, among which 14 were monitored e 30 non-monitored, from January 2012 to December 2012, using data from Siscolo. Results: The monitored laboratories showed 1,837 altered tests, with 855 atypical squamous cells, 905 intraepithelial lesions and 350 high grade intraepithelial lesions, while the non- monitored laboratories showed 2,535 altered tests, with 1,436 atypical squamous cells, 890 intraepithelial lesions, and 244 high grade intraepithelial lesions. Approximately 60% of the monitored laboratories and 26% of the non- monitored ones showed a positivity rate of ≥ 3%, while 72% of the monitored laboratories and 10% of the non- monitored ones showed a percentage of ≥ 0.4% of the tests compatible with high grade intraepithelial lesion among satisfactory tests. Approximately 7% of the monitored laboratories and 29% of the non-monitored ones showed a percentage of ≥ 60% of atypical squamous with undetermined significance among the altered studies. Conclusion: Most laboratories that presented indicators within the recommended parameters were participating in the monitoring process of external quality.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/443
10.32635/2176-9745.RBC.2014v60n4.443
url https://rbc.inca.gov.br/index.php/revista/article/view/443
identifier_str_mv 10.32635/2176-9745.RBC.2014v60n4.443
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/443/262
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 60 No. 4 (2014): Oct./Nov./Dec.; 295-303
Revista Brasileira de Cancerologia; Vol. 60 Núm. 4 (2014): oct./nov./dic.; 295-303
Revista Brasileira de Cancerologia; v. 60 n. 4 (2014): out./nov./dez.; 295-303
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042243712843776

Registros relacionados